Vijaypd Ceutical Ltd.

VIJAYPD

Equity

NSE

Min. Investment

35,000.00

Open a free Demat account and invest in IPOs easily.

Download Orca

Google PlayApp Store

To access realtime data for GP Eco Solutions India Ltd. and use advance features for Applying IPO. Register or Login to Orca.

IPO Details

Bidding Dates

29 Sept 25 - 01 Oct 25

Price Range ₹

35 - 0

Total Equity

18.55Cr

Lot Size

8000

Exchange Status

NSE

IPO Doc

Subscription Rate

Non-Institutional Investor

0.00×

Qualified Institutional Buyers

0.00×

Employees

0.00×

Retail Investors

0.00×

Total subscription Rate

0.00×

IPO Timeline

Offer start

29 Sept 2025

Offer end

01 Oct 2025

Allotment

03 Oct 2025

Refund initiation

06 Oct 2025

Demat transfer

06 Oct 2025

Listing

07 Oct 2025

About Company

Vijaypd Ceutical Limited, incorporated in October 1971, is a long-established distributor of pharmaceutical products and consumer goods with a strong presence in the pharmaceutical, wellness, and FMCG markets. The company operates as representatives, dealers, agents, stockists, suppliers, traders, and packers, offering a wide range of products that include medicines (such as injections, tablets, capsules, ointments, suppositories, ophthalmic solutions, and oral liquids), vitamins, hormones, enzymes, tonics, serums, diagnostic kits, personal care items like soaps and sanitizers, baby care essentials, ayurvedic products, cosmetics, food items, dental products, and crude drugs. With FDA, FSSAI, and BMC certifications, the company ensures quality and compliance in its distribution practices. As of March 31, 2025, Vijaypd Ceutical serves over 2,109 pharmacies, clinics, and nursing homes across four districts and 20 locations, supported by a strong distribution network linked with more than 170 healthcare manufacturers and a portfolio exceeding 19,000 SKUs. This extensive product range allows the company to cater to diverse healthcare and consumer needs while maintaining supply chain efficiency and reliability. Its competitive strengths include long-standing client relationships, a comprehensive product portfolio, streamlined supply chain management, and an experienced management team with proven industry expertise.

Year Founded

19-03-2024

Promotor Details

Samit Madhukar Shah

Promoter Holdings Details

ParticularPre-IPOPost-IPO
Percentage74.850
Share Capital105006860

Offer to Public

53,00,000.00 Cr

Highlights

  • Over 50 years in business, building trust and strong relationships in pharmaceutical and FMCG distribution.
  • Revenue up 98% and PAT up 191% in FY2025, showing strong operational performance.
  • Access to over 19,000 SKUs across pharmaceuticals, wellness, FMCG, and ayurvedic categories.
  • Serves 2,100+ pharmacies, clinics, and nursing homes across 20 locations, connected with 170+ manufacturers.
  • Holds FDA, FSSAI, and BMC certifications, ensuring product quality and credibility.

Challenges

  • PAT margin at 4.49% and EBITDA margin at 8.04% remain modest despite strong revenue growth.
  • Debt-to-equity at 0.68 indicates moderate leverage, with reliance on borrowings for growth.
  • Operations currently limited to four districts, which may restrict scalability compared to larger national distributors.
  • Faces intense competition from large pharmaceutical distributors and FMCG supply chains.
  • Heavy reliance on 170+ suppliers; disruptions in supply or pricing pressure could impact business.

Financials

YearsTotal AssetsShare CapitalProfit After TaxConsolidated Net ProfitAdjusted EPS
20255,710.001,402.87479.55479.553.4183
Enrich money logo